- Home
- RCEL vs INV Comparison
RCEL vs INV Comparison
Compare RCEL & INV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RCEL
- INV
- Stock Information
- Founded
- RCEL N/A
- INV 2015
- Country
- RCEL United States
- INV United States
- Employees
- RCEL N/A
- INV N/A
- Industry
- RCEL Medical/Dental Instruments
- INV
- Sector
- RCEL Health Care
- INV
- Exchange
- RCEL Nasdaq
- INV NYSE
- Market Cap
- RCEL 161.5M
- INV 173.3M
- IPO Year
- RCEL N/A
- INV N/A
- Fundamental
- Price
- RCEL $5.19
- INV $5.01
- Analyst Decision
- RCEL Strong Buy
- INV Strong Buy
- Analyst Count
- RCEL 4
- INV 2
- Target Price
- RCEL $16.50
- INV $14.00
- AVG Volume (30 Days)
- RCEL 287.8K
- INV 121.7K
- Earning Date
- RCEL 08-07-2025
- INV 08-15-2025
- Dividend Yield
- RCEL N/A
- INV N/A
- EPS Growth
- RCEL N/A
- INV N/A
- EPS
- RCEL N/A
- INV N/A
- Revenue
- RCEL $71,661,000.00
- INV $1,220,000.00
- Revenue This Year
- RCEL $57.29
- INV $1,045.66
- Revenue Next Year
- RCEL $28.07
- INV $240.46
- P/E Ratio
- RCEL N/A
- INV N/A
- Revenue Growth
- RCEL 41.35
- INV 18.27
- 52 Week Low
- RCEL $5.10
- INV $3.00
- 52 Week High
- RCEL $14.16
- INV $18.75
- Technical
- Relative Strength Index (RSI)
- RCEL 29.07
- INV N/A
- Support Level
- RCEL $5.10
- INV N/A
- Resistance Level
- RCEL $6.33
- INV N/A
- Average True Range (ATR)
- RCEL 0.32
- INV 0.00
- MACD
- RCEL 0.02
- INV 0.00
- Stochastic Oscillator
- RCEL 6.10
- INV 0.00
About RCEL Avita Medical Inc.
Avita is a single product company. Its RECELL system is an innovative burn treatment device which creates Spray-on Skin from a small skin sample within 30 minutes, thus avoiding or reducing the need for skin grafts. It's approved for the treatment of adult and paediatric patients in the US and an expanded indication for soft-tissue reconstruction. It is currently in roll-out across the approximately 136 US burn centers. Despite having product approval in Australia, Europe, Canada, and China, Avita is not actively marketing in those territories and focussing instead on the US region. However, it is expected to launch in Japan via distribution partner Cosmotec in second-half fiscal 2022. Avita is domiciled, and has its primary listing, in the US.
About INV INNVENTURE INC
Innventure Inc creates, funds, operates, and rapidly scales companies in strategic collaboration with MNCs. It provides company creation, corporate strategy, technology optimization, operations, commercialization, and funding. Innventure analyzes the market, including proprietary data provided by MNCs, to identify where their well-protected, breakthrough technologies address market needs and have the potential to create $1B+ in new enterprise value.